190 related articles for article (PubMed ID: 6879022)
21. [Serological evaluation of immunization against measles with 2 doses administered at 6 and 11 months of age: a prospective study].
Pannuti CS; de Souza VA; Sato HK; Fink MC; Ribeiro MI; Hisi SK; Castelo A; de Mendonça JS
Rev Inst Med Trop Sao Paulo; 1990; 32(6):450-5. PubMed ID: 2135492
[TBL] [Abstract][Full Text] [Related]
22. Comparison of vaccination with measles-mumps-rubella vaccine at 9, 12, and 15 months of age.
Redd SC; King GE; Heath JL; Forghani B; Bellini WJ; Markowitz LE
J Infect Dis; 2004 May; 189 Suppl 1():S116-22. PubMed ID: 15106100
[TBL] [Abstract][Full Text] [Related]
23. Age-dependent differences in IgG isotype and avidity induced by measles vaccine received during the first year of life.
Nair N; Gans H; Lew-Yasukawa L; Long-Wagar AC; Arvin A; Griffin DE
J Infect Dis; 2007 Nov; 196(9):1339-45. PubMed ID: 17922398
[TBL] [Abstract][Full Text] [Related]
24. Introduction to the control of measles by vaccination in the People's Republic of China.
Zhiang Y; Su W
Rev Infect Dis; 1983; 5(3):568-73. PubMed ID: 6879016
[TBL] [Abstract][Full Text] [Related]
25. Field trial of a heat-stable measles vaccine in Papua New Guinea.
Climie A; André FE
J Trop Med Hyg; 1984 Dec; 87(6):249-55. PubMed ID: 6534989
[TBL] [Abstract][Full Text] [Related]
26. Effectiveness of vaccination at 6 to 11 months of age during an outbreak of measles.
de Serres G; Boulianne N; Ratnam S; Corriveau A
Pediatrics; 1996 Feb; 97(2):232-5. PubMed ID: 8584383
[TBL] [Abstract][Full Text] [Related]
27. Immune responses to measles immunization and the impacts on HIV-infected children.
Thaithumyanon P; Punnahitananda S; Thisyakorn U; Praisuwanna P; Ruxrungtham K
Southeast Asian J Trop Med Public Health; 2000 Dec; 31(4):658-62. PubMed ID: 11414407
[TBL] [Abstract][Full Text] [Related]
28. Measles antibody in mothers and infants 0-2 years and response to measles vaccine at the age of 9 and 18 months.
Techasena W; Sriprasert P; Pattamadilok S; Wongwacharapipoon P
J Med Assoc Thai; 2007 Jan; 90(1):106-12. PubMed ID: 17621740
[TBL] [Abstract][Full Text] [Related]
29. Gender differences in the reactogenicity of measles-mumps-rubella vaccine.
Shohat T; Green MS; Nakar O; Ballin A; Duvdevani P; Cohen A; Shohat M
Isr Med Assoc J; 2000 Mar; 2(3):192-5. PubMed ID: 10774264
[TBL] [Abstract][Full Text] [Related]
30. Optimal age for measles vaccination.
Vidyashankar C
J Indian Med Assoc; 2002 Jan; 100(1):24-6. PubMed ID: 12206338
[TBL] [Abstract][Full Text] [Related]
31. Early loss of passive measles antibody in infants of mothers with vaccine-induced immunity.
Maldonado YA; Lawrence EC; DeHovitz R; Hartzell H; Albrecht P
Pediatrics; 1995 Sep; 96(3 Pt 1):447-50. PubMed ID: 7651776
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of measles antibodies before and after vaccination in previously unvaccinated children of the Cordillera Province (Santa Cruz Department, Bolivia).
Guglielmetti P; Bianchi Bandinelli ML; Bartoloni A; Gamboa H; Roselli M; Valensin PE
J Trop Med Hyg; 1994 Aug; 97(4):231-5. PubMed ID: 8064946
[TBL] [Abstract][Full Text] [Related]
33. [Immuno-epidemiologic considerations on the prevention of measles in Mexico].
Díaz-Ortega JL; Valdespino-Gómez JL; Zárate-Aquino ML; Camacho-Amor ML; González-Velázquez MS; Chávez-San Juan R
Bol Med Hosp Infant Mex; 1990 Jul; 47(7):474-81. PubMed ID: 2206412
[TBL] [Abstract][Full Text] [Related]
34. Measles immunity after revaccination: results in children vaccinated before 10 months of age.
Linnemann CC; Dine MS; Roselle GA; Askey PA
Pediatrics; 1982 Mar; 69(3):332-5. PubMed ID: 7063289
[TBL] [Abstract][Full Text] [Related]
35. Measles control in a rural area in Zimbabwe.
Tumwine JK
East Afr Med J; 1991 Sep; 68(9):694-701. PubMed ID: 1797531
[TBL] [Abstract][Full Text] [Related]
36. Girls may have lower levels of maternal measles antibodies and higher risk of subclinical measles infection before the age of measles vaccination.
Martins C; Bale C; Garly ML; Rodrigues A; Lisse IM; Andersen A; Eriksson M; Benn CS; Whittle H; Aaby P
Vaccine; 2009 Aug; 27(38):5220-5. PubMed ID: 19596409
[TBL] [Abstract][Full Text] [Related]
37. Effect of vitamin A supplementation on measles vaccination in nine-month-old infants.
Semba RD; Akib A; Beeler J; Munasir Z; Permaesih D; Muherdiyantiningsih ; Komala ; Martuti S; Muhilal
Public Health; 1997 Jul; 111(4):245-7. PubMed ID: 9242038
[TBL] [Abstract][Full Text] [Related]
38. Reduced seroconversion to measles in infants given vitamin A with measles vaccination.
Semba RD; Munasir Z; Beeler J; Akib A; Muhilal ; Audet S; Sommer A
Lancet; 1995 May; 345(8961):1330-2. PubMed ID: 7752754
[TBL] [Abstract][Full Text] [Related]
39. Measles vaccine efficacy in India: a review.
Singh J; Datta KK
J Commun Dis; 1997 Mar; 29(1):47-56. PubMed ID: 9282529
[TBL] [Abstract][Full Text] [Related]
40. [The combined measles-yellow fever vaccination in African infants aged 6 to 10 months].
Mouchon D; Pignon D; Vicens R; Tu-Ha-Thanh ; Tekaia F; Teulières L; Garrigue G
Bull Soc Pathol Exot; 1990; 83(4):537-51. PubMed ID: 2286007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
